Personalizing Endocrine Therapy Plans: Help Patients with Early-Stage, HR+ Breast Cancer Find Clarity About What’s Next

Editor's Note: The following article was originally written and shared with us by Adriana Olivo, NP, Memorial Sloan Kettering Cancer Center. For many people with hormone receptor-positive (HR+), early-stage breast…

Continue Reading Personalizing Endocrine Therapy Plans: Help Patients with Early-Stage, HR+ Breast Cancer Find Clarity About What’s Next

Navigating the Challenges of Biomarker Testing in Oncology: Innovations for Low-Yield Samples

Biomarker analysis plays a pivotal role in cancer care and research, guiding the development of targeted therapies and enabling personalized treatment plans. While next-generation sequencing (NGS) has revolutionized the ability…

Continue Reading Navigating the Challenges of Biomarker Testing in Oncology: Innovations for Low-Yield Samples